# CKX Lands, Inc.: financial statements, quarterly

CKX · NYSE · CIK 352955 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ckx.md) · [Financials](/companies/ckx/financials.md) · [Filings](/companies/ckx/filings.md) · [Insiders](/companies/ckx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ckx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [259](/filings/0001437749-24-034224.md) | [690 d](/filings/0001437749-25-009075.md) | [142](/filings/0001437749-25-016019.md) | [1,027](/filings/0001437749-25-025633.md) | [171](/filings/0001437749-25-034052.md) | [181 d](/filings/0001437749-26-010434.md) | [348](/filings/0001437749-26-015951.md) | [136](/filings/0001437749-26-026519.md) | [233](/filings/0001437749-25-034052.md) | [122 d](/filings/0001437749-26-010434.md) | [171](/filings/0001437749-26-015951.md) | [168](/filings/0001437749-26-026519.md) |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [3.8](/filings/0001437749-24-034224.md) | [359 d](/filings/0001437749-25-009075.md) | [(437)](/filings/0001437749-25-016019.md) | [646](/filings/0001437749-25-025633.md) | [(16.9)](/filings/0001437749-25-034052.md) | [(75.6) d](/filings/0001437749-26-010434.md) | [112](/filings/0001437749-26-015951.md) | [160](/filings/0001437749-26-026519.md) | [113](/filings/0001437749-25-034052.md) | [3,256 d](/filings/0001437749-26-010434.md) | [(74.8)](/filings/0001437749-26-015951.md) | [23.1](/filings/0001437749-26-026519.md) |
| Income tax | $k | [11.9](/filings/0001437749-24-034224.md) | [172 d](/filings/0001437749-25-009075.md) | [14.9](/filings/0001437749-25-016019.md) | [145](/filings/0001437749-25-025633.md) | [(16.9)](/filings/0001437749-25-034052.md) | [(56.0) d](/filings/0001437749-26-010434.md) | [90.2](/filings/0001437749-26-015951.md) | [73.2](/filings/0001437749-26-026519.md) | [(2.6)](/filings/0001437749-25-034052.md) | [806 d](/filings/0001437749-26-010434.md) | [13.3](/filings/0001437749-26-015951.md) | [31.0](/filings/0001437749-26-026519.md) |
| Net income | $k | [35.7](/filings/0001437749-24-034224.md) | [242 d](/filings/0001437749-25-009075.md) | [(401)](/filings/0001437749-25-016019.md) | [565](/filings/0001437749-25-025633.md) | [54.1](/filings/0001437749-25-034052.md) | [32.2 d](/filings/0001437749-26-010434.md) | [116](/filings/0001437749-26-015951.md) | [161](/filings/0001437749-26-026519.md) | [166](/filings/0001437749-25-034052.md) | [2,567 d](/filings/0001437749-26-010434.md) | [55.2](/filings/0001437749-26-015951.md) | [122](/filings/0001437749-26-026519.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001437749-24-034224.md) | not reported | [1991337.00](/filings/0001437749-25-016019.md) | [0.27](/filings/0001437749-25-025633.md) | [0.03](/filings/0001437749-25-034052.md) | not reported | [0.06](/filings/0001437749-26-015951.md) | [0.08](/filings/0001437749-26-026519.md) | [0.08](/filings/0001437749-25-034052.md) | not reported | [0.03](/filings/0001437749-26-015951.md) | [0.06](/filings/0001437749-26-026519.md) |
| Basic EPS | $ per share | [0.02](/filings/0001437749-24-034224.md) | not reported | [(0.20)](/filings/0001437749-25-016019.md) | [0.28](/filings/0001437749-25-025633.md) | [0.03](/filings/0001437749-25-034052.md) | not reported | [0.06](/filings/0001437749-26-015951.md) | [0.08](/filings/0001437749-26-026519.md) | [0.08](/filings/0001437749-25-034052.md) | not reported | [0.03](/filings/0001437749-26-015951.md) | [0.06](/filings/0001437749-26-026519.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [8.7](/filings/0001437749-23-031306.md) | [9.4](/filings/0001437749-25-009075.md) | [9.0](/filings/0001437749-24-016203.md) | [9.7](/filings/0001437749-24-026102.md) | [9.5](/filings/0001437749-24-034224.md) | [9.6](/filings/0001437749-26-010434.md) | [9.8](/filings/0001437749-25-016019.md) | [9.9](/filings/0001437749-25-025633.md) | [14.7](/filings/0001437749-25-034052.md) | [18.1](/filings/0001437749-26-026519.md) | [18.1](/filings/0001437749-26-015951.md) | [17.6](/filings/0001437749-26-026519.md) |
| Total assets | $m | [18.2](/filings/0001437749-23-031306.md) | [18.8](/filings/0001437749-25-009075.md) | [18.4](/filings/0001437749-24-016203.md) | [19.0](/filings/0001437749-24-026102.md) | [18.7](/filings/0001437749-24-034224.md) | [18.8](/filings/0001437749-26-010434.md) | [22.3](/filings/0001437749-26-015951.md) | [18.9](/filings/0001437749-25-025633.md) | [19.2](/filings/0001437749-25-034052.md) | [22.3](/filings/0001437749-26-026519.md) | [22.3](/filings/0001437749-26-015951.md) | [21.9](/filings/0001437749-26-026519.md) |
| Current liabilities | $m | [0.1](/filings/0001437749-23-031306.md) | [0.5](/filings/0001437749-25-009075.md) | [0.4](/filings/0001437749-24-016203.md) | [0.5](/filings/0001437749-24-026102.md) | [0.2](/filings/0001437749-24-034224.md) | [0.3](/filings/0001437749-26-010434.md) | [0.3](/filings/0001437749-25-016019.md) | [0.2](/filings/0001437749-25-025633.md) | [0.3](/filings/0001437749-25-034052.md) | [0.7](/filings/0001437749-26-026519.md) | [0.7](/filings/0001437749-26-015951.md) | [0.1](/filings/0001437749-26-026519.md) |
| Total liabilities | $m | [0.1](/filings/0001437749-23-031306.md) | [0.5](/filings/0001437749-25-009075.md) | [0.4](/filings/0001437749-24-016203.md) | [0.5](/filings/0001437749-24-026102.md) | [0.2](/filings/0001437749-24-034224.md) | [0.3](/filings/0001437749-26-010434.md) | [0.3](/filings/0001437749-25-016019.md) | [0.2](/filings/0001437749-25-025633.md) | [0.3](/filings/0001437749-25-034052.md) | [0.8](/filings/0001437749-26-026519.md) | [0.8](/filings/0001437749-26-015951.md) | [0.3](/filings/0001437749-26-026519.md) |
| Shareholders' equity | $m | [18.1](/filings/0001437749-24-034224.md) | [18.3](/filings/0001437749-26-010434.md) | [18.0](/filings/0001437749-25-025633.md) | [18.5](/filings/0001437749-25-034052.md) | [18.6](/filings/0001437749-25-034052.md) | [18.6](/filings/0001437749-26-026519.md) | [18.7](/filings/0001437749-26-026519.md) | [18.7](/filings/0001437749-26-026519.md) | [18.9](/filings/0001437749-25-034052.md) | [21.4](/filings/0001437749-26-026519.md) | [21.5](/filings/0001437749-26-026519.md) | [21.6](/filings/0001437749-26-026519.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [148 d](/filings/0001437749-24-034224.md) | [625 d](/filings/0001437749-25-009075.md) | [(338)](/filings/0001437749-25-016019.md) | [692 d](/filings/0001437749-25-025633.md) | [(247) d](/filings/0001437749-25-034052.md) | [97.4 d](/filings/0001437749-26-010434.md) | [119](/filings/0001437749-26-015951.md) | [(24.6) d](/filings/0001437749-26-026519.md) | [242 d](/filings/0001437749-25-034052.md) | [123 d](/filings/0001437749-26-010434.md) | [(52.3)](/filings/0001437749-26-015951.md) | [(412) d](/filings/0001437749-26-026519.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001437749-23-031306.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $k | [0.0 d](/filings/0001437749-24-034224.md) | [0.0 d](/filings/0001437749-25-009075.md) | [0.0](/filings/0001437749-25-016019.md) | [0.0 d](/filings/0001437749-25-025633.md) | [0.0 d](/filings/0001437749-25-034052.md) | [0.0 d](/filings/0001437749-26-010434.md) | [0.0](/filings/0001437749-26-015951.md) | [0.0](/filings/0001437749-26-026519.md) | [0.0 d](/filings/0001437749-25-034052.md) | [0.0 d](/filings/0001437749-26-010434.md) | not reported | [0.0](/filings/0001437749-26-026519.md) |
| Share repurchases | $k | [0.0 d](/filings/0001437749-24-034224.md) | [87.2 d](/filings/0001437749-25-009075.md) | not reported | not reported | [0.0 d](/filings/0001437749-25-034052.md) | [0.0 d](/filings/0001437749-26-010434.md) | not reported | not reported | [0.0 d](/filings/0001437749-25-034052.md) | [0.0 d](/filings/0001437749-26-010434.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,946](/filings/0001437749-23-023257.md) | [1,973](/filings/0001437749-23-031306.md) | [2,037](/filings/0001437749-24-026102.md) | [2,285](/filings/0001437749-24-034224.md) | [2,063](/filings/0001437749-25-025633.md) | [2,064](/filings/0001437749-25-034052.md) | [2,027](/filings/0001437749-26-015951.md) | [2,049](/filings/0001437749-26-026519.md) | [2,053](/filings/0001437749-25-034052.md) | [2,053](/filings/0001437749-26-015951.md) | [2,053](/filings/0001437749-26-026519.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,053,129 at 2026-08-06, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026519.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.